zoloft store link
 
top2-3
Contact Us contactus Ελληνικά flag
top3-3
THE SOCIETY
NATIONAL CONGRESS
WORKING GROUPS SEMINARS
REGIONAL CONGRESSES OF THE HELLENIC CARDIOLOGICAL SOCIETY
SCIENTIFIC PROGRAMS
WORKING GROUPS-OLD STRUCTURE
WORKING GROUPS-NEW STRUCTURE
EDUCATION
HELLENIC JOURNAL OF CARDIOLOGY
CALENDAR
LINKS
INTERNATIONAL JOURNALS
PATIENT NEWS
WEBINARS
GUIDELINES
YOUNG CARDIOLOGISTS
ACTIONS OF THE HELLENIC CARDIOLOGICAL SOCIETY
NEWS FROM ESC
STUDIES
 
Clinical Issues
REVIEWS
Prevention
Imaging
Arterial Hypertention
Valvular Heart Disease
Thromboembolism Disease
Αrrhythmias
Coronary Artery Disease
Cardiomyopathies
Heart Failure
more>>
INTERVIEWS
Atrial Fibrillation
Myocardial Infarction. How much are we at risk?
more>>
 
ESC Guidelines
COMPENDIUM of Abridged ESC Guidelines 2010
European Resuscitation Council Guidelines for Resuscitation 2010 Section 1. Executive summary
Prevention of Cardiovascular Disease
Hypertension
more>>
Special Links
 
Special Releases
NEW PUBLICATIONS
more>>
 
challenge
Herodotos
Panos Vardas, ESC President 2012-2014 HCS
Scientific Highlights
ESC 2014 Barcelona 30Aug-4Sep
PARADIGM-HF: Investigational new heart failure drug, an angiotensin receptor-neprilysin inhibitor (ARNI) known as LCZ696, could be poised...
The new 2014 ESC/ESA Guidelines
The new 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management is now available The 2014 ESC/ESA...
Pradaxa antidote receives breakthrough therapy designation from FDA
Boehringer Ingelheim announced that the FDA has granted breakthrough therapy designation to its investigational drug idarucizumab, which is...
FDA approved Sapien XT for high-risk, inoperable patients
Edwards Lifesciences has announced that its second-generation transcatheter valve, Sapien XT, has received FDA approval for the treatment of...
FDA approval expands access of Core Valve to high-risk patients
The FDA has today approved the use of the self-expanding CoveValve transcatheter valve for patients with severe aortic stenosis who are at high...
AHA Provides Guidance on Noninvasive Tests to Evaluate Suspected IHD in Women
The American Heart Association (AHA) has published a new consensus statement on the use of noninvasive testing to evaluate women with...
Societies publish recommendations for transcatheter mitral valve procedures
The Centers for Medicare & Medicaid Services -CMS issued a decision memo proposing coverage for certain cases of transcatheter mitral valve...
Societies publish recommendations for transcatheter mitral valve procedures
Four societies have published a set of recommendations that outline criteria necessary for institutions in the implementation and maintenance of...
FDA approves Zontivity to reduce MI, stroke in high-risk patients
The FDA has approved vorapaxar to reduce the risk for MI, stroke, CV-related death and coronary revascularization among patients who have...
FDA approves Entovis pacemaker for use during MRI
Biotronik announced that the FDA has approved both single- and dual-chamber versions of its Entovis pacemaker system with ProMRI technology,...
FDA approves Epanova for severe hypertriglyceridemia
The FDA has approved the use of Epanova, in addition to diet, for the reduction of triglycerides in adults with severe...
AHA ISSUES FETAL HEART DISEASE GUIDANCE
Recognizing the fetus as a patient, the American Heart Association (AHA) has released a scientific statement that addresses the diagnosis and...
FDA PROPOSES REGULATIONS FOR ELECTRONIC CIGARETTES
The FDA today released its proposed regulations for electronic cigarettes. The new regulations extend the Tobacco Control Act to include coverage...
AHA/ACC/HEART RHYTHM SOCIETY RELEASE UPDATED AF MANAGEMENT GUIDELINE
The American Heart Association, American College of Cardiology and Heart Rhythm Society have released the 2014 Guideline for the Management of...
ACC 2014, 29-31 MARCH WASHINGTON
SYMPLICITY HTN-3 presented: Renal denervation misses primary efficacy endpoint The SYMPLICITY HTN-3 trial although was found safe, failed to show...
ΡANOLAZINE FOR THE TREATMENT OF REFRACTORY CHRONIC STABLE ANGINA PECTORIS AS DETERMINED FROM A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED CLINICAL TRIALS
Despite the use of traditional antianginal medication (beta-blockers, calcium channel blockers, and nitrates) and revascularization, symptoms of...
RANOLAZINE IS COST – EFFECTIVE IN PATIENTS WITH REFRACTORY ANGINA
I this study evaluated the cost- effectiveness of ranolazine when added to standard-of-care (SoC) antianginals in patients with stable coronary...
BETA BLOCKERS AND PERIOPERATIVE CARE: EUROPEAN HEART JOURNAL EDITORIAL ADDRESSES CONTROVERSY
Since the end of 2011 when the scientific work of Professor Don Poldermans was first scrutinized there has been controversy in the medical world...
NEW GUIDELINES OUTLINE STROKE RISKS UNIQUE TO WOMEN
A new set of guidelines on the prevention of stroke in women calls for the development of a female-specific stroke risk score and recommends...
GUIDELINES ISSUED FOR DIAGNOSIS, TREATMENT OF HF IN CHILDREN
The Canadian Cardiovascular Society has issued guidelines on the presentation, diagnosis and medical management of HF in children. Can J...
more>>
Case Reports
 
GIANT CARDIAC HYDATID CYST WITH RARE ADHESIONS We present a 29-year-old woman admitted... QUADRICUSPID PULMONARY VALVE IN AN ADULT PATIENT We describe a case of quadricuspid pulmonary...
 
more>>
Hot Articles
META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS COMPARING SHORT-TERM VERSUS LONG-TERM DUAL ANTIPLATELET THERAPY FOLLOWING DRUG-ELUTING STENTS Current guidelines recommend 12 months of dual antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation in the absence of increased bleeding risk. Studies have suggested that...
HPS2-THRIVE PUBLISHED: NIACIN DID NOT BENEFIT PATIENTS WITH VASCULAR DISEASE Confirming findings presented at the American College of Cardiology 2013 Scientific Sessions, the HPS2-THRIVE data published in The New England Journal of Medicine indicate that...
BETA-BLOCKERS MOST EFFECTIVE IN PATIENTS WITH RECENT MI For patients with new-onset CHD, use of beta-blockers was associated with lower risk for cardiac events only in patients with a recent MI. Previous research demonstrated...
SUCCESSFUL CTO PCI MAY IMPROVE LONG-TERM SURVIVAL Successful chronic total occlusion PCI was associated with a reduction in mortality of nearly 30% in a large cohort of patients from the United Kingdom, according to results of a retrospective...
BETA-BLOCKER USE BEFORE CABG NOT LINKED TO IMPROVED OUTCOMES Preoperative beta-blocker use by patients undergoing nonemergency CABG was not associated with improved outcomes, including perioperative mortality, according to a database...
ROCKET AF: XARELTO SIMILAR TO WARFARIN FOR SAFETY, EFFICACY IN ELDERLY PATIENTS The efficacy and safety of rivaroxaban relative to warfarin did not differ with age, which suggests that rivaroxaban is a viable alternative in patients aged at least 75 years, according to new...
OBSERVATIONAL RESULTS SHOW BENEFIT OF BETA-BLOCKERS AT DISCHARGE AFTER PCI Patients who underwent primary PCI for STEMI and received beta-blockers at discharge experienced approximately 50% lower mortality than those who did not receive beta-blockers at...
Mesenchymal stromal stem cell injection improved heart function in patients with HF Intramyocardial injection of mesenchymal stromal stem cells derived from bone marrow improved end-systolic volume, quality of life and other outcomes in patients with severe ischemic heart...
CORP-2: Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis In this multicentre, double-blind, placebo-controlled, randomised trial colchicine added to conventional anti-inflammatory treatment significantly reduced the rate of subsequent recurrences of...
New study challenges concept of ‘healthy obesity’ Obese adults who display no signs of CVD appear to have a significantly higher prevalence of coronary artery calcification compared with normal-weight adults. J Am Coll Cardiol. ...
VITAMIN D SUPPLEMENTATION HAS NO EFFECT ON CV, CANCER OR SKELETAL OUTCOMES Vitamin D supplementation does not appear to prevent MI, stroke, cancer or bone fractures and results of future trials are unlikely to yield different conclusions, according to a series of...
HERPES ZOSTER INCREASED RISK FOR STROKE, TIA, MI IN YOUNG PEOPLE Herpes zoster is an independent risk factor for stroke, transient ischemic attack and MI in people whose cases occurred when they were younger than 40 years, according to recent study...
more>>
HCS NEWS
ESC Congress News 2014
September 11 2014
Please find below the most important ESC Congress News 2014 SATURDAY 30 AUGUST SUNDAY 31 AUGUST MONDAY 1 SEPTEMBER TUESDAY 2 SEPTEMBER WEDNESDAY...
INAUGUAL SESSION ESC Congress 2014
August 19 2014
INAUGUAL SESSION ESC Congress 2014 Saturday 30 August Barcelona - Central Village 16:30-18:00 We invite all delegates to join this...
Catalogue with the most influential Greek scientists‏
August 7 2014
The list with the most influential Greek scientists is part of a study conducted by Prof. John Ioannidis (University of Ioannina &...
RAFFTING PUBLICATION IN THE INTERNATIONAL JOURNAL OF CARDIOLOGY
August 1 2014
Results from the official Registry of the Hellenic Society of Cardiology RAFTING (Registry of Atrial Fibrillation To Investigate New Guidelines)...
35th INTERNATIONAL CARDIOLOGICAL CONGRESS- ABSTRACT SUBMISSION
May 26 2014
We would like to inform you that the deadline for abstract submission is extended until 30/5/2014.
HEART FAILURE 2014- Athens 17-20 May, OPENING CEREMONY
May 13 2014
35th INTERNATIONAL CARDIOLOGICAL CONGRESS- ABSTRACT SUBMISSION
May 7 2014
We would like to inform you that the deadline for abstract submission is extended until 18/5/2014.
HEART FAILURE 2014- Athens 17-20 May, Free Registration for Greek Residents
April 24 2014
Cardiology Update 2015 21st International Postgraduate Course on Cardiovascular Disease
April 8 2014
EUROPEAN HEART JOURNAL CARDIOVASCULAR IMAGING
March 25 2014
Volume: 15 / Number: 4 / Publication Date: March 2014 / Owner: European Society of Cardiology
U.E.M.S. Cardiology Section
February 13 2014
Dear delegates to UEMS Cardiology Section, this is to notify you that the European Society of Cardiology (ESC) and UEMS Cardiology Section (CS),...
EUROPEAN HEART JOURNAL CARDIOVASCULAR IMAGING
January 28 2014
Volume: 15 / Number: 2 / Publication Date: February 2014 / Publisher: European Society of Cardiology
REGISTRATION AT HEART FAILURE 2014 IN ATHENS
January 21 2014
Τhe HFA Board has designed special prices for the Greek participants: -Free for Local Medical Students -200€ for local...
INNOVATION IN EDUCATION AT WORK
January 20 2014
For more information please click here.
SURGERY IN SEVERE MITRAL REGURGITATION: FOCUS ON PATIENTS WITH NO SYMPTOMS OR COMPLICATIONS
An article from the e-journal of the ESC Council for Cardiology Practice Mitral valve repair is often recommended in severe mitral regurgitation...
HEART FAILURE 2014 ABSTRACT SUBMISSION
Abstract submission deadline: 21 January 2014. For more information please click here.
PRESS RELEASE ABOUT SYMPLICITY HTN-3
In light of Medtronic’s announcement of Thursday, 9th January 2014, about SYMPLICITY HTN-3, the Resistant Hypertension Course Scientific...
New insights regarding management of diabetes
Cardiologists are frontline specialists when it comes to preventing diabetes and cardiovascular disease. We especially cannot escape managing...
EUROPEAN HEART JOURNAL CARDIOVASCULAR IMAGING
Volume: 15 / Number: 1 / Publication Date: January 2014 / Publisher: European Society of Cardiology
EUROINTERVENTION-OFFICIAL JOURNAL OF EUROPCR
Volume 9/Number 8 - December 2013
more >>
cardiomap

 
 
6 Potamianou 11528 Athens
Phone: +30 210 722 1633, 210 725 8003-8
Fax: +30 210 722 6139
 
facebook    twitter
 
    Sponsors
Powered: By Inspirit Graphics Studio